Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Seed Health Closes $40 Million in Series A Financing
Seed Health, a microbial sciences company developing next-generation probiotic applications and live biotherapeutics, today announced […]
Saudi Arabia Pharmaceutical Drugs Market to Surpass US$ 16,663.1 Million by 2027, Says Coherent Market Insights (CMI)
According to Coherent Market Insights, the Saudi Arabia pharmaceutical drugs market is estimated to be […]
Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced […]
FDA Grants Accelerated Approval for GSK’s JEMPERLI (dostarlimab-gxly) for Women with Recurrent or Advanced dMMR Endometrial Cancer
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has […]
Government Launches Covid-19 Antivirals Taskforce to Roll out Innovative Home Treatments This Autumn
A new Antivirals Taskforce has been launched by the government to identify treatments for UK […]
Moderna New Supply Agreement with Israel for 2022
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a […]
Nanoform and Aprecia collaborate to advance 3D printed Nanomedicines
Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Aprecia, the 3DP (three-dimensional printing) […]
Syneos Health Partners with Medable, Expanding Decentralized Solutions to Bring Clinical Trials Closer to the Patient
Syneos Health®, the only fully integrated biopharmaceutical solutions organization, and Medable, the leading cloud platform […]
OS Therapies Completes $6 Million Series A Funding Round
OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and […]
Gain Therapeutics Announces Multi-Target Drug Discovery Collaboration Agreement with Zentalis Pharmaceuticals
Gain Therapeutics, Inc. today announced a multi-target collaboration agreement with Zentalis Pharmaceuticals to discover new product candidates […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more